Clinical Trials Logo
  1. Home
  2. Transsexualism
  3. NCT00135148
  4. Details
NCT00135148 Clinical Trial

Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group

Transsexualism Clinical Trial

Official title:
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00135148
Other study ID # 2004/341
Secondary ID
Status Completed
Phase N/A
First received August 24, 2005
Last updated December 19, 2007
Start date April 2004
Est. completion date August 2005

Study information
Verified date December 2007
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Observational

Clinical Trial Summary

Participants fill out a questionnaire on libido and their possible partner relationship.

A blood sample is taken for sex steroid analysis.

Description:

Participants fill out a questionnaire on libido and their possible partner relationship on the website http://www.onderzoek-libido.be.

A blood sample is taken for sex steroid analysis. The relation will be investigated between testosterone, free testosterone, sex hormone binding globulin, estradiol, DHEA and androstenedione and scores on relational and sexual satisfaction and sexual desire.

Recruitment information / eligibility
Status Completed
Enrollment 150
Est. completion date August 2005
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Transsexual women with completed adaptation of the sex (all surgical procedures and hormonal treatments)

- The female control group must be 18-45 years

Study Design

N/A

Related Conditions & MeSH terms

Intervention

Procedure:
• Filling out a questionnaire on libido and possible partner relationship

• Sex steroid analysis

Locations
Country Name City State
Belgium University Hospital Ghent Ghent

Sponsors (2)
Lead Sponsor Collaborator
University Hospital, Ghent Organon

Country where clinical trial is conducted

Belgium, 

See also
  Status Clinical Trial Phase
Recruiting NCT05487794 - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis N/A
Completed NCT02185274 - Observational Study on Metabolism and Psychopathology in Transsexual Patients
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Completed NCT00146146 - Testosterone and Its Metabolites in GID Phase 3
Completed NCT04864951 - HPV Prevalence in Transpersons - a Prospective Study N/A
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Completed NCT00435513 - A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism Phase 0
Recruiting NCT03637920 - Sexuality in Transmen During Hormone and Operative Treatment
Completed NCT03823014 - Use of an External Erectile Device in Transgender Man Following Phalloplasty N/A
Recruiting NCT03872648 - TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
Completed NCT01065220 - Sex Steroids and the Serotonin Transporter Phase 4
Enrolling by invitation NCT03595956 - Transgender Cohort Study of Gender Affirmation and HIV-related Health
Completed NCT02119377 - First Australian National Trans Mental Health Study N/A
Completed NCT02518009 - GEnder Dysphoria Treatment in Sweden

External Links